Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells
Abstract Background Liver cancer stem cells (LCSCs) are a small subset of cells characterized by unlimited self-renewal, cell differentiation, and uncontrollable cellular growth. LCSCs are also resistant to conventional therapies and are thus believed to be held responsible for causing treatment fai...
Main Authors: | Dong-Mei Wu, Zi-Hui Zheng, Ying-Bo Zhang, Shao-Hua Fan, Zi-Feng Zhang, Yong-Jian Wang, Yuan-Lin Zheng, Jun Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-019-1239-3 |
Similar Items
-
LncRNA DLX6-AS1 Promotes the Progression of Neuroblastoma by Activating STAT2 via Targeting miR-506-3p
by: Hu Y, et al.
Published: (2020-08-01) -
LncRNA ZFAS1: Role in tumorigenesis and other diseases
by: Soudeh Ghafouri-Fard, et al.
Published: (2021-10-01) -
Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer
by: Hongxu Li, et al.
Published: (2021-07-01) -
LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer
by: Yong An, et al.
Published: (2018-09-01) -
LncRNA GAS8‐AS1 downregulates lncRNA NEAT1 to inhibit glioblastoma cell proliferation
by: Xiaoming Wu, et al.
Published: (2021-06-01)